| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Methionine (MET) restriction (MR) has been shown to arrest cancer growth and sensitizes tumors to chemotherapy. -Many cancer cells rely heavily on exogenous methionine to sustain rapid growth and proliferation because they often have impaired methionine salvage pathways. -Methionine contributes to the synthesis of glutathione, a key antioxidant. (Methionine is a precursor of glutathione, a tripeptide that reduces reactive oxygen species.) -MR diets might influence the redox state of cancer cells, increasing oxidative stress and thereby leading to cell death in metabolically compromised tumor cells. -Proliferation and growth of several types of cancer cells are inhibited by MR, while normal cells are unaffected by limiting methionine as long as homocysteine is present. -Methionine restriction is effective when the non-essential amino acid, cysteine, is absent from the diet or media. methionine is the precursor for cysteine which is essential for the formation of GSH. -Malignant cells lack the enzyme required to recycle homocysteine therefore giving methionine restriction the capacity to alter cancer cells while maintaining normal, healthy cells. While vegan diets are typically low in methionine, some nuts and legumes (such as Brazil nuts and kidney beans) are rich in methionine. Foods to avoid for MR diet: Animal Proteins: -Red Meat (Beef, Pork, Lamb): -Poultry (Chicken, Turkey): -Fish and Seafood: -Eggs: Both the egg whites and yolks are protein rich. -Dairy Products: Milk, cheese, and yogurt Certain Plant Proteins: -Soy Products: -Legumes: Protein Supplements: Foods Lower in Methionine (Often Favorable on an MR Diet) Fruits & Vegetables: leafy greens, berries, apples, and citrus fruits. Grains & Cereals: rice, oats, and barley Nuts and Seeds: can vary in methionine content. Alternative Protein Sources: emphasize protein sources with a lower methionine-to-cysteine ratio.
|
| Source: |
| Type: |
| Tumor cells display a peculiar “methionine dependency” (i.e. an increased need for exogenous methionine), and many enzymes in methionine metabolism are dysregulated in malignancy. MAT1A,– Primarily expressed in adult liver. -Decreased MAT1A expression or loss of MAT1A activity is associated with reduced production of S‐adenosylmethionine (SAM) and can contribute to malignant transformation. MAT2A -Elevated MAT2A expression is often correlated with enhanced proliferation and a worse prognosis, given its role in maintaining SAM levels in rapidly dividing tumor cells. -In cancers outside the liver, upregulation of MAT2A and methionine transporters (along with downstream effects on methylation) signify aggressive behavior and may be used as prognostic indicators. May be desirable to reduce Methionine in diet, and/or use AKBA to help reduce it, before chemo. |
| 1893- | dietMet, | Clinical Studies of Methionine-Restricted Diets for Cancer Patients |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:292 Target#:1206 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid